Tazopen Indications/Uses

Piperacillin and Tazobactam Sodium is indicated for the treatment of patients with moderate to severe infections caused by penicillin-resistant, piperacillin/tazobactam-susceptible, (beta)-lactamase producing strains of the designated microorganisms in the specified conditions listed as follows: Appendicitis (complicated by rupture or abscess) and peritonitis caused by piperacillin-resistant, (beta)-lactamase producing strains of Escherichia coli or the following members of Bacteroides fragilis group: B. fragilis, B. ovatus, B. thetaiotamicron, or B. vulgatus.
Uncomplicated and complicated skin and skin structure infections, including cellulitis, cutaneous abscesses and ischemic/diabetic foot infections caused by piperacillin-resistant, (beta)-lactamase producing strains of Staphylococcus aureus.
Postpartum endometritis or pelvic inflammatory disease caused by piperacillin-resistant, (beta)-lactamase producing strains of Escherichia coli.
Community-acquired pneumonia (moderate severity only) caused by piperacillin-resistant, (beta)-lactamase producing strains (Haemophilus influenzae).
Nosocomial pneumonia (moderate to severe) caused by piperacillin-resistant, (beta) lactamase producing strains of Staphylococcus aureus.